Empery Asset Management, LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$81.4M2026 Q3+ $15.1M options (notional, not included)
Positions34
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.88.4%

Empery Asset Management, LP reported 34 positions worth $81.4M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: XFOR (29.2%). Biggest move: new buy MODERNA INC ($14.1M).

10 / 34 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 XFORX4 Pharmaceuticals$28.2M29.23%9,725,509——+7.6%
▸ 2 EMPDEmpery Digital$14.5M15.07%4,830,345——-38.2%
▸ 3ModernaPutModerna$14.1M notional14.63%73,300———
▸ 4 OTLKOutlook Therapeutics$12.2M12.63%21,247,856——-23.3%
▸ 5 NGENNervgen Pharma$6.3M6.55%3,308,973———
▸ 6Zone FrontierZone Frontier$2.6M2.69%20,000,000———
▸ 7 PYXSPyxis Oncology$2.3M2.41%1,000,000——-32.2%
▸ 8 CLRBCellectar Biosciences$1.8M1.82%955,118———
▸ 9 AMLXAmylyx Pharmaceuticals$1.7M1.81%60,000——-4.5%
▸ 10 DYAIDyadic$1.5M1.54%3,346,275——-9.3%

Pro Feature

The remaining 24 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Empery Asset Management, LP hold as of Q3 2026?

Empery Asset Management, LP reported 34 positions worth $81.4M in its Q3 2026 13F filing. Largest positions: XFOR (29.2%), EMPD (15.1%), MODERNA INC (14.6%), OTLK (12.6%) and NGEN (6.5%).

What did Empery Asset Management, LP buy in Q3 2026?

New positions: MODERNA INC, OTLK, ZONE FRONTIER INC, PYXS and AMLX (10 in all). Added to: XFOR, EMPD, CLRB and CYNGN INC.

What did Empery Asset Management, LP sell in Q3 2026?

Reduced: DTIL, CLNN, NGEN, TNYA and ONE AND ONE GREEN TECHNOLOGI (9 in all). Sold out entirely: ANVS, AMC, VENU HLDG CORP, SCYX and REIN THERAPEUTICS INC (8 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.